Mercia Pharma Company
Mercia Pharma is a biotechnology company. Their services include autoimmune disease, chronic disease, infectious disease, insulin b chain, diabetes, conjugated vaccine, alzheimer's, a conjugated vaccine for asthma, adjuvant for influenza, and neutralizing antibodies, therapeutic and prophylactic vaccines.
Industry:
Geroscience
Headquarters:
New York, New York, United States
Zip:
11-50
Founded Date:
2002-01-01
Employees Number:
11-50
Total Funding:
$1M to $10M
Estimated Revenue:
$1M to $10M
Last Funding Type:
blackburn.p@merciapharma.com
Register and Claim Ownership